SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin shines as its Goa manufacturing facility gets EIR from USFDA

14 Dec 2021 Evaluate

Lupin is currently trading at Rs. 939.45, up by 55.35 points or 6.26% from its previous closing of Rs. 884.10 on the BSE.

The scrip opened at Rs. 890.00 and has touched a high and low of Rs. 972.50 and Rs. 882.55 respectively. So far 310410 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1267.50 on 02-Jun-2021 and a 52 week low of Rs. 854.05 on 07-Dec-2021.

Last one week high and low of the scrip stood at Rs. 972.50 and Rs. 870.00 respectively. The current market cap of the company is Rs. 40366.54 crore.

The promoters holding in the company stood at 46.83%, while Institutions and Non-Institutions held 40.41% and 12.76% respectively.

Lupin has received the Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) for its Goa manufacturing facility, after the inspection of the facility in September 2021. The USFDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI). The company has committed to manufacture and supply products of the highest quality from all manufacturing sites.

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.

Lupin Share Price

2459.75 17.40 (0.71%)
07-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1834.40
Dr. Reddys Lab 1306.80
Cipla 1362.85
Zydus Lifesciences 940.10
Lupin 2459.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×